BOSULIF (Bosutinib) 100mg ,120 tablets in one bottle • 500mg ,30 tablets in one bottle

BOSULIF (Bosutinib)

About Medicine

  • Name: BOSULIF
  • Generic Name: Bosutinib
  • Strength: 100 mg and 500 mg
  • Company: PFIZER
  • Packing: 100mg contain 120 tablets in one bottle and 500mg contain 30 tablets in one bottle
Get Price
Categories: ,

Description

(BOSULIF is registered trademarks PFIZER)

Bosulif – Bosutinib 100 mg and 500 mg is supplied for Tenders, Emergency imports, Orphan drug, Reference listed drugs, Comparator Drug, Name patient medicine, and Innovator samples, etc.

What is BOSULIF:

BOSULIF is a medicine that contains the active substance Bosutinib and is available as tablets.

In how many countries BOSULIF is approved for marketing?

BOSULIF is available/approved in USA and Europe. We can help you to access it in India.

What is BOSULIF used for?

BOSULIF is indicated for the treatment of adult patients with chronic, accelerated, or blast phase Ph+ chronic myelogenous leukemia (CML) with resistance or intolerance to prior therapy.

How can I get BOSULIF in India?

BOSULIF is a prescription only drug and is not approved for marketing in India.

The Indian Pharma (IP) is a consulting pharmaceutical company which assists Patients in accessing medicines in India. The Indian Pharma facilitates such access only against valid prescriptions in conformity with all local laws and regulations.

Patients/ Clinicians / Researchers can contact IP at +91-120-4080562 or write to at – info@theindianpharma.com

We facilitate by-

  • Helping in documentation to import the medicine for personal use
  • Finding Genuine and reliable source in USA, Europe and Japan
  • Ensuring 100% transparency.

BOSULIF can be shipped to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Jaipur, Lucknow, Cochin and Pune and other cities in India.

The Indian Pharma can facilitate the supply of BOSULIF (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement.

The Indian Pharma does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturers or licensees

FAQ

Can I get BOSULIF even if I am not based in India? Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country The Indian Pharma (IP) can help patients in accessing/importing BOSULIF, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country. Send your enquiry to find-
  • BOSULIF in South East Asia – China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
  • BOSULIF in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
  • BOSULIF in North America – Mexico.
  • BOSULIF in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
  • BOSULIF in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
  • BOSULIF in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
  • BOSULIF in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
  • BOSULIF in Australia and New Zealand.
How is BOSULIF used? BOSULIF should be administered under the guidance of specialist doctor having experience in managing cancer treatments. Recommended dose: 500 mg orally once daily with food. • Consider dose escalation to 600 mg daily in patients who do not reach complete hematologic response by week 8 or complete cytogenetic response by week 12 and do not have Grade 3 or greater adverse reactions. If the patient develops certain serious side effects then doctor may interrupt or stop treatment, or reduce the dose. See the summary of product characteristics on company official website for more information Are there any side-effects/ adverse reactions/precautions associated with treatment with BOSULIF? It is recommended to seek your doctor’s medical advice about side effects How do I contact The Indian Pharma? You can use different channel to contact The Indian Pharma (IP) Tele & Mobile: You can reach us on +91 8826990915 or +91-120-4080562 on any working days. Email: We can also address your enquiries if sent directly to info@theindianpharma.com. We will respond within 24 hours after receiving your mail. Please mention detailed enquiry, your contact number with ISD code while sending your mail. We will respond within 1 working days after receiving your query form.

Documentation of BOSULIF

What information do you need to help patient in assisting documentation for BOSULIF import for personal use? We will require the following documents to help in documentation for Named-Patient import
  • Doctor’s Prescription – We would require prescription from Registered Medical Practitioner Stating Product name, dosage, duration of treatment and diagnosis
  • Patient’s Medical history – We would require all test reports and Medical reports of the patient for last 3 months.
  • Patient’s Identity card – We will require scan copy of Patient’s identity card and proof of residence to initiate documentation process. You can use copy of Passport, Driving License, Employee ID card or any Photo ID document as your Identity card.

Related products

× How can I Help you?